… and Korea) with newly diagnosed NSCLC and EGFR mutation (exon 19 deletion or exon 21
… Randomization was stratified by race and EGFR mutation type. An ad hoc updated analysis …

… 7 trial compared afatinib with gefitinib as a first-line treatment in patients with advanced
NSCLC harboring common EGFR mutations (Del19 and the L858R point mutation) [8]. Although …

… L858R mutation later in tumor evolution consistent with previous reports inherited susceptibility
of lung cancer and heterogeneous development of sensitizing EGFR mutations in these …

… There is a need for a broader EGFR panel beyond looking at the EGFR T790M mutation, so
… a qPCR-based EGFR mutation panel that also includes the activating EGFR mutations. The …

… with HER3-DXd and EGFR-TKI in EGFR-mutated NSCLC that is currently … EGFR-mutated
NSCLC tumors, not only with regard to an acquired resistance to EGFR-TKI but also in EGFR-…

… lung cancer (NSCLC) tumors harboring mutations in EGFR ultimately relapse to therapy with
EGFR tyrosine kinase inhibitors (EGFR … T790M or other acquired mutations are sensitive to …

… I allotypes with the highest number of predicted binding EGFR neoantigens (<500 nM affinity)
for the most prevalent shared EGFR mutations in lung cancer. Black arrows indicate the A*…

… Erlotinib versus standard chemotherapy as first-line treatment for European patients with
advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-…

… Epidermal growth factor receptor (EGFR) tyrosine kinase … with EGFR mutation-positive
non-small-cell lung cancer (… EGFR TKIs for the first-line treatment of EGFR mutation-positive …

… EGFR-mutated-positive compared with EGFR-wild-type AC tissues. We also found EGFR
mutations … the regions with higher ions intensity of phospholipids were EGFR-mutated-positive. …